跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
臺北醫學大學器官移植研究中心
臺北醫學大學
概覽
指紋
網路
專家檔案
(23)
專案
(1)
研究成果
(615)
指紋
查看啟用 臺北醫學大學器官移植研究中心 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Chronic Kidney Disease
75%
Cohort Analysis
73%
Meta-Analysis
72%
Systematic Review
52%
Randomized Controlled Trial
44%
Hepatocellular Carcinoma
40%
Hazard Ratio
37%
Hepatectomy
36%
Breast Cancer
36%
Dry Eye
35%
Aortic Dissection
29%
Chemoradiotherapy
28%
Eye Disease
27%
Diseases
27%
Neoplasm
25%
End Stage Renal Disease
24%
Endovascular Aneurysm Repair
24%
Cardiovascular Disease
24%
Quality of Life
21%
Kidney Function
21%
Non Small Cell Lung Cancer
18%
Nephropathy
18%
Radiation Therapy
18%
Cancer Cell
18%
Diabetes
18%
All Cause Mortality
18%
Myocardial Infarction
18%
Proportional Hazards Model
17%
Odds Ratio
16%
Biopsy Technique
16%
Percutaneous Vertebroplasty
15%
Kidney Transplantation
15%
Incision
15%
Kidney Graft
15%
Overall Survival
15%
Chemotherapy
15%
Surgeon
14%
Acute Kidney Injury
14%
Esophageal Squamous Cell Carcinoma
14%
Hyperthermic Intraperitoneal Chemotherapy
14%
Cholangiocarcinoma
14%
Abdominal Aortic Aneurysm
14%
Rectum Cancer
14%
Malignant Neoplasm
14%
Retrospective Cohort Study
14%
Prevalence
14%
Computer Assisted Tomography
13%
Mortality Rate
13%
Hematoma
13%
Lung Cancer
13%
Epidermal Growth Factor Receptor
12%
Clinical Stage
12%
Kidney Injury
12%
Heart Surgery
12%
Kyphoplasty
12%
Oral
12%
Magnetic Resonance Imaging
12%
Apoplexy
12%
Liver Transplantation
12%
Cancer Growth
11%
Programmed Cell Death
11%
Intensity Modulated Radiation Therapy
11%
Hemodialysis
11%
Arrhythmogenesis
11%
Vertebra
11%
Antithrombotic
11%
Survival Rate
11%
Congestive Heart Failure
11%
Health Care Cost
11%
Disease Free Survival
11%
Observational Study
10%
Transitional Cell Carcinoma
10%
Cytoreductive Surgery
10%
Erectile Dysfunction
10%
Kyphosis
10%
4 Iodo 2,5 Dimethoxyamphetamine
10%
Extracorporeal Shockwave Therapy
10%
Prediction Model
10%
Disseminated Herpes Zoster
10%
Recurrent Disease
10%
Tumor
10%
Adverse Event
10%
Hemodynamic
10%
Subgroup Analysis
10%
Osteoporotic Vertebral Compression Fracture
10%
Cancer
9%
Propensity Score Matching
9%
Sepsis
9%
Spine Surgery
9%
Adenocarcinoma
9%
Lung Adenocarcinoma
9%
Deterioration
9%
Cardiovascular System
9%
Visual Impairment
9%
Reoperation
9%
Diabetes Mellitus
9%
Division
9%
Upregulation
8%
Retrospective Study
8%
Nephrology
8%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
95%
Malignant Neoplasm
55%
Liver Cell Carcinoma
53%
Cohort Study
43%
Breast Cancer
41%
Neoplasm
41%
Epidermal Growth Factor Receptor
36%
Randomized Controlled Trial
35%
Inflammation
33%
Non Small Cell Lung Cancer
32%
Protein Kinase B
27%
Diseases
26%
Cytotoxicity
24%
Cancer Growth
24%
Chemotherapy Regimens
23%
Reactive Oxygen Metabolite
23%
End Stage Renal Disease
22%
Colorectal Carcinoma
22%
Hemodialysis
21%
Cardiovascular Disease
20%
Placebo
20%
Dry Eye
20%
Catenin
19%
Nanoparticle
19%
Abdominal Cancer
19%
Aortic Dissection
18%
Vaccination
18%
Cisplatin
18%
Drug Resistance
17%
Lung Cancer
17%
Adverse Event
16%
Nicotinic Receptor
16%
Influenza
16%
Hyaluronic Acid
16%
Eye Disease
15%
Ferroptosis
15%
microRNA
15%
Cytokine
15%
Paclitaxel
15%
Abdominal Aortic Aneurysm
14%
Castration Resistant Prostate Cancer
14%
Bladder Cancer
13%
Maturity Onset Diabetes of the Young
13%
Western Blot
12%
Carcinogenesis
12%
Therapeutic Effect
12%
Vasculotropin
12%
Mouse Model
12%
All Cause Mortality
11%
Immunogenicity
11%
Deterioration
11%
Fucoidan
11%
Arrhythmogenesis
11%
Recurrent Disease
11%
Vismodegib
11%
Prostate Cancer
11%
Carbon Monoxide Poisoning
10%
Cornea Neovascularization
10%
Dicer
10%
Nanocomposite
10%
Zinc Oxide
10%
Cell Viability
10%
Hedgehog
10%
Peptide
10%
Observational Study
10%
Gemcitabine
9%
Replacement Therapy
9%
Receptor
9%
Acute Kidney Failure
9%
Interleukin 6
8%
Wound Healing
8%
Monotherapy
8%
Galectin 3
8%
Nitric Oxide
8%
Infection
8%
Diabetes Mellitus
8%
Anti-Inflammatory Drug
8%
Polysaccharide
8%
Programmed Death 1 Ligand 1
8%
Anticoagulant Agent
8%
Sodium Ion
8%
Epidermal Growth Factor Receptor Kinase Inhibitor
8%
Hyperthermia
8%
Fluorouracil
8%
Epigallocatechin Gallate
8%
Disease Exacerbation
8%
Mitogen Activated Protein Kinase 3
7%
Diterpenoid
7%
Fibrosis
7%
Angiotensin Receptor Antagonist
7%
Adverse Effect
7%
Wound
7%
Janus Kinase
7%
Mouth Squamous Cell Carcinoma
7%
Tumor Growth
7%
Antiinflammatory Activity
7%
Aortic Valve Disease
7%
Atrial Fibrillation
7%
Ranibizumab
7%
SARS Coronavirus
7%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
MicroRNA
32%
Dicer
29%
Methylation
28%
Stem Cell
28%
Epidermal Growth Factor Receptor
27%
Protein Kinase B
26%
Carcinogenesis
25%
Glucose-Regulated Protein
25%
Signal Transduction
25%
Upregulation
24%
Gemcitabine
23%
Cell Migration
22%
Metabolic Pathway
21%
Cancer Stem Cell
20%
Messenger RNA
20%
Ferroptosis
19%
Drug Resistance
19%
Fibroblast
18%
down Regulation
17%
Overall Survival
16%
Programmed Cell Death
16%
Tumor Progression
16%
Mesenchymal-Epithelial Transition
16%
Cisplatin
15%
Survivin
15%
Colon
15%
Anticancer
15%
Autophagy
14%
Oxidative Stress
14%
Single-Nucleotide Polymorphism
14%
Cell Growth
13%
Small Interfering RNA
13%
Cell Proliferation
13%
CD44
13%
Cohort Study
13%
Molecular Mechanism
12%
Catenin
12%
Synapsin I
12%
Polysaccharide
11%
Macrophage
10%
Ubiquitin Ligase
10%
Matrix Metalloproteinase
10%
Polygenic Score
10%
Blood Plasma
10%
Genetics
10%
Differentially Expressed Gene
10%
Histone Deacetylase
10%
Transactivation
9%
Staining
9%
Promoter Region
9%
Gefitinib
9%
Hydrogen Peroxide
9%
Genetic Divergence
9%
Comorbidity
9%
Sorafenib
8%
Gene Expression
8%
Vascular Endothelial Growth Factor
8%
Cell Survival
8%
Atrial Fibrillation
8%
Bone Density
8%
Cytokine
8%
Anti-Inflammatory
8%
Cell Viability
8%
Heat Shock Protein
7%
Genotyping
7%
Kidney Function
7%
Expression Level
7%
Tyrosine Kinase Inhibitor
7%
Western Blot
7%
Platelet-Rich Plasma
7%
Wound Healing
7%
Snail
7%
Protein Expression
7%
P53
7%
Thrombomodulin
7%
Nuclear Factor I
7%
Galectin-3
7%
Endothelin
7%
Tumor-Associated Macrophage
7%
Mammalian Target of Rapamycin
7%
KRAS
7%
Proline
7%
Glycolysis
7%
MMP9
7%
Gelatinase B
7%
T Cell
7%
Mitochondrial Disorder
7%
Oxidoreductase
7%
Ubiquitin-Conjugating Enzyme
6%
Mouse Model
6%
MTT Assay
6%
Genome-Wide Association Study
6%
DNA Methylation
6%
Cardiac Muscle Cell
6%
Small Hairpin RNA
6%
Tumor Suppressor Protein
6%
Dendritic Cell
6%
Lipid Metabolism
6%
Lipopolysaccharide
6%